BLACK FRIDAY EARLY — BOGO 50% SITEWIDE

HGH Fragment 176-191: What It Is, What Research Has Studied, and What the Evidence Actually Shows

By the Ageless Humans editorial team · Updated 2026-11-14 · 7 min read

HGH Fragment 176-191 is a small synthetic peptide copied from the tail end of the human growth hormone molecule. Researchers have studied it mainly for fat metabolism, because animal studies suggest it may encourage fat breakdown without the broader growth-promoting effects of full growth hormone. The human evidence is thin and mixed, it is not approved for any medical use, and it is banned in sanctioned sport.

What Is HGH Fragment 176-191?

HGH Fragment 176-191 is a 16-amino-acid peptide that matches amino acids 176 through 191 of human growth hormone (hGH). Full growth hormone is a 191-amino-acid protein, so this fragment is a small piece cut from its C-terminal, or "tail," end. Scientists isolated this region because early work suggested it might hold much of growth hormone's fat-metabolism activity.

The idea behind it is simple. Growth hormone does many things in the body, including tissue growth, effects on blood sugar, and signaling through IGF-1. Researchers wanted to know if they could keep one narrow effect, fat breakdown, and drop the rest. The fragment was their attempt.

You'll often see a closely related compound called AOD-9604 in the same conversations. AOD-9604 is a modified version of this region of hGH with an extra amino acid added for stability. Much of the published human research was done on AOD-9604, not the plain 176-191 fragment. That matters when you read claims online, because results from one are often credited to the other.

If you're new to this category, our guide to what peptides are covers the basics: short chains of amino acids that act as signaling molecules. For a quick reference card on this compound, see our HGH Fragment 176-191 peptide overview.

What Has HGH Fragment 176-191 Been Studied For?

The research focuses almost entirely on fat metabolism, meaning how fat cells release and store fat. A smaller body of work has looked at cartilage and joint tissue. Here is how the research breaks down:

  • Fat breakdown (lipolysis): Rodent and cell studies suggest the fragment may increase the release of stored fat from fat cells.
  • Fat storage (lipogenesis): The same lines of research suggest it may reduce the formation of new fat in fat tissue.
  • Weight management in humans: The modified version, AOD-9604, went through human clinical development for weight management. That program did not produce results strong enough to reach approval.
  • Cartilage and joint tissue: Some animal research has explored AOD-9604 injected into joints in models of cartilage damage. This work is early and limited.

The pattern is common in peptide research. Promising results in cells and rodents create interest. Then the harder question, whether the effect holds up in people at meaningful levels, gets a weaker or less clear answer.

How Is It Thought to Work? The Proposed Mechanisms

The leading theory is that HGH Fragment 176-191 acts directly on fat tissue to promote fat release, and does so without fully activating the growth hormone receptor. That second part is the point of the molecule. Full growth hormone binds its receptor and starts a chain of effects, including a rise in IGF-1. Studies of the fragment suggest it does not meaningfully raise IGF-1. That is why it's described as "non-growth-promoting."

Researchers have proposed a few pathways:

1. Direct action on fat cells. In lab studies, the fragment appears to stimulate the cell machinery that breaks stored triglycerides into usable fatty acids. 2. Beta-3 adrenergic involvement. Some rodent research suggests the fat-burning effect may depend partly on beta-3 adrenergic receptors. These receptors are prominent in rodent fat tissue and help regulate energy use. Humans have fewer of them, which may help explain why rodent results don't carry over cleanly. 3. Less impact on blood sugar handling. Full growth hormone can affect how the body manages glucose. Early research suggested the fragment may not share that effect to the same degree. This is still being worked out, not settled.

The honest summary: the mechanism story makes sense on paper and has support in animal models. It has not been mapped out well in humans.

What the Human Evidence Actually Shows

The human evidence is limited, mostly comes from AOD-9604 rather than the plain fragment, and did not show a strong enough effect for weight-management approval. This is the most important section of this article, and it's the part most online sources leave out.

AOD-9604 was developed as a pharmaceutical candidate and tested in human clinical trials. Early-phase studies were reported as encouraging and generally well tolerated. A larger later-stage trial did not show a meaningful difference from placebo on its main weight outcome, and the developer stopped pursuing it as a weight-management drug. We are describing the general outcome here, not quoting figures, because specifics vary by trial and are easy to misstate.

So where does that leave the plain 176-191 fragment? Its human data is thinner still. Most of what is said about it in forums and vendor listings is pieced together from:

  • Rodent and cell studies
  • AOD-9604 human trials, applied to a different molecule
  • Personal reports, which can't separate the peptide's effect from diet, training, or placebo

What the research does not show: that HGH Fragment 176-191 reliably reduces body fat in people, that it is safe for long-term use, or that it matches the effects of full growth hormone. Anyone telling you otherwise is going beyond the evidence.

Legal, Regulatory, and Sport Status

HGH Fragment 176-191 is not approved by the FDA for any use, and it is prohibited in sanctioned sport. In the US, it's mostly sold as a "research chemical" labeled not for human consumption. That label means no one is vouching for its purity, dosing, or safety in people.

The World Anti-Doping Agency (WADA) lists growth hormone fragments, and names both AOD-9604 and hGH 176-191, on its prohibited list. Athletes subject to testing should treat it as banned at all times.

Regulators have also taken a closer look at AOD-9604 in pharmacy compounding, citing open questions about safety data. Rules here change, so check current guidance and talk with a licensed clinician before considering any unapproved peptide.

Safety Unknowns and Real-World Risks

The biggest risks with HGH Fragment 176-191 are unknown long-term safety and unreliable product quality. Early AOD-9604 trials were reported as generally well tolerated over their study periods. But short trials on a related molecule don't tell you much about years of use of a different one.

The practical risks are often bigger than the pharmacology:

  • Purity and identity. Research-chemical vendors aren't held to supplement or drug manufacturing standards. What's in the vial may not match the label.
  • Contamination and handling. Injectable products bring sterility concerns that oral supplements don't.
  • Delivery. Like most peptides, this fragment breaks down quickly and is poorly absorbed by mouth. That's why research has used injection. Oral "HGH fragment" products deserve extra skepticism.

We don't give dosing guidance for research compounds. If you're weighing an unapproved peptide, the right next step is a conversation with a qualified healthcare provider.

How It Compares to Other Peptides and Bioregulators

HGH Fragment 176-191 is a narrow, single-target research peptide, which sets it apart from broader recovery peptides and from short bioregulator peptides. It helps to know where it fits.

  • Versus full growth hormone: The fragment was designed to isolate one effect, fat metabolism, and to avoid growth hormone's wider actions such as raising IGF-1. It is not a substitute for growth hormone and doesn't replicate its effects.
  • Versus recovery peptides like BPC-157 and TB-500: These have been studied for tissue repair and recovery, mostly in animal models. They target a different goal than fat metabolism.
  • Versus bioregulators: Bioregulators are very short peptides, often two to four amino acids, studied for supporting specific tissues. Our guide to what bioregulators are explains the category.

The takeaway is that "peptide" covers a huge range of molecules. Results for one peptide tell you almost nothing about another, so judge each on its own evidence.

The Bottom Line on HGH Fragment 176-191

HGH Fragment 176-191 is an interesting research peptide with a reasonable mechanism and weak human proof. Animal studies suggest it may support fat breakdown without the growth effects of full growth hormone. The closest human research, on AOD-9604, did not deliver results strong enough for approval.

If your goal is body composition, the basics still carry the evidence: consistent resistance training, enough protein, good sleep, and steady daily movement. Supplements can play a supporting role in that routine. They aren't a replacement for it.

If your interest in peptides is about recovery or overall healthy aging, focus on products made to clear quality standards and paired with honest claims. That's the standard we hold ourselves to: every Ageless Humans product is made in our FDA-registered facility in Carlsbad, California, every lot is third-party lab tested with a COA, and every order is backed by a 60-day money-back guarantee.

Related reading & products

Frequently asked questions

What is HGH Fragment 176-191 used for?+

HGH Fragment 176-191 has been studied mainly for fat metabolism, especially fat breakdown in animal and cell models. It is not approved by the FDA for any use and is mostly sold as a research chemical. Human evidence for body-fat effects is limited and mixed.

Does HGH Fragment 176-191 actually work for fat loss?+

Rodent research suggests HGH Fragment 176-191 may promote fat breakdown, but those results haven't clearly carried over to people. The closest human research, on the related peptide AOD-9604, did not show a strong enough effect in a larger trial to win approval for weight management. There is no reliable proof that it reduces body fat in humans.

Is HGH Fragment 176-191 the same as AOD-9604?+

No, but they are closely related. AOD-9604 is a modified version of the same tail region of growth hormone, with an extra amino acid added for stability. Most published human trials used AOD-9604, so results are often wrongly credited to the plain 176-191 fragment.

Does HGH Fragment 176-191 raise growth hormone or IGF-1?+

Research suggests HGH Fragment 176-191 does not meaningfully raise IGF-1 or act like full growth hormone. It was designed to isolate growth hormone's fat-metabolism activity without its broader growth effects. That means it is not a substitute for growth hormone.

Is HGH Fragment 176-191 legal or banned in sports?+

HGH Fragment 176-191 is not FDA-approved and is typically sold in the US as a research chemical not intended for human use. The World Anti-Doping Agency names both hGH 176-191 and AOD-9604 on its prohibited list. Tested athletes should treat it as banned at all times.

Does Ageless Humans sell HGH Fragment 176-191?+

No. Ageless Humans does not sell HGH Fragment 176-191, and this article is for education only. The brand makes oral supplements, including peptide-based recovery support, in its FDA-registered facility in Carlsbad, California, with third-party lab testing on every lot.

Keep reading